Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous

4 trials RRespiratory

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

0 Recruiting

2 Completed trials

3 Sponsors

10 Countries

Phase III

Phase IV

Phase III: 2 Phase IV: 2

Indications tested

Sponsors using this IMP

Chiesi Farmaceutici S.p.A. 2 Hospices Civils De Lyon 1 LETI Pharma S.L.U. 1

All trials

4 total

A clinical trial to evaluate the efficacy and safety of a mixture of allergenic extracts of D. pteronyssinus and D. farinae, in patients suf… Pending

2025-521230-29-00 Phase III 1 country LETI Pharma S.L.U.
BETRI-Prospective: Asthma control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 µg]) vs Single Inhaler ICS/LABA (200/… Pending

2025-524289-56-00 Phase IV 8 countries Chiesi Farmaceutici S.p.A.
Symptoms control and adhErenCe assessment during treatment with mepolizUmab new pREfilled devices. SECURE Ended

2022-501029-19-00 Phase IV 1 country Hospices Civils De Lyon
A study comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF5993 With the Fixed Dose Dual Combination CHF153… Ended

2023-510172-31-00 Phase III 5 countries Chiesi Farmaceutici S.p.A.

Showing 1–4 of 4 trials

← All drugs A–Z